Buscar resultados de ensayos clínicos
Carcinoma, Ductal - 30 Studies Found
| Estado | Estudiar |
| Not yet recruiting |
Nombre del estudio: Neo-adjuvant FOLF(IRIN)OX for Resectable Pancreatic Adenocarcinoma Condición: Resectable Pancreatic Duct Adenocarcinoma Fecha: 2016-11-03 Intervenciones:
|
| Completed |
Nombre del estudio: Evaluation of Percutaneous Treatment by Cryoablation of Unifocal Invasive Breast Carcinoma in Menopausal Women With Indication of Lumpectomy Condición:
Fecha: 2015-10-12 Intervenciones: Device: Cryoablation Other Name: Cryotherapy |
| Completed |
Nombre del estudio: Comparison of Operative to Monitoring and Endocrine Therapy (COMET) Trial For Low Risk DCIS Condición:
Fecha: 2016-09-19 Intervenciones:
|
| Completed |
Nombre del estudio: Clinical Outcome of Chemotherapy in Surgical Patients With Infiltrating Ductal Carcinoma of Breast Condición: Breast Cancer Fecha: 2016-08-25 Intervenciones:
|
| Terminated |
Nombre del estudio: Vitamin D3 (Vit D3) Supplementation and T Cell Immunomodulation in Patients With Newly Diagnosed Operative Invasive Ductal Breast Carcinoma Condición: Newly Diagnosed Operative Invasive Ductal Breast Carcinoma Stage I-II Fecha: 2013-02-06 Intervenciones: Dietary Supplement: Vitamin D Subjects will be assigned to a dosage level between 600IU daily and 10,000 |
| Completed |
Nombre del estudio: Lapatinib Ditosylate in Treating Patients With Ductal Breast Carcinoma In Situ Condición:
|
| Completed |
Nombre del estudio: Neoadjuvant Therapy in TRIPle Negative Breast Cancer With antiPDL1 Condición: Invasive Ductal Breast Carcinoma Fecha: 2015-11-03 Intervenciones:
|
| Completed |
Nombre del estudio: Lumpectomy Followed By Intraoperative Electron Radiation Therapy (IOERT) Condición:
Intervenciones: Radiation: Intraoperative Electron Radiotherapy Intraoperative Electron Radiotherapy (IOERT) is delivere |
| Recruiting |
Nombre del estudio: Nelipepimut-S Plus GM-CSF Vaccine Therapy in Treating Patients With Breast Cancer Condición: Ductal Breast Carcinoma In Situ Fecha: 2015-12-18 Intervenciones:
|
| Completed |
Nombre del estudio: G1T38, a CDK 4/6 Inhibitor, in Combination With Fulvestrant in Hormone Receptor-Positive, HER2-Negative Locally Advanced or Metastatic Breast Cancer Condición:
|